Form 4: Director Shweta Maniar Receives Orthofix Stock Grant

Director Shweta Maniar was granted 14,965 deferred stock units by Orthofix Medical Inc. as part of an equity award.

Summary

• Director Shweta Maniar acquired 14,965 deferred stock units (DSUs) on June 10, 2026.
• The grant represents a contingent right to receive one share of common stock per unit.
• The units vest in full on the first anniversary of the grant date, contingent upon continued service.
• Following this transaction, the director's total beneficial ownership increased to 69,038 shares, including previously reported DSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in nature.

Positives

• The equity grant aligns the director's interests with those of shareholders through long-term stock ownership.

Negatives

• None identified.

Risks

• Vesting is subject to the director's continued service with the issuer through the first anniversary of the grant date.

Future Outlook

The deferred stock units will vest on June 10, 2027, and will settle into common stock within 45 days of the director's termination of service.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the medical device industry to ensure alignment with long-term shareholder value.

Comparison to Industry Standards

• The use of deferred stock units for director compensation is consistent with standard practices among mid-cap medical technology companies.
• The vesting schedule of one year is typical for non-employee director equity awards.

Stakeholder Impact

• Shareholders: Increased alignment of director interests with long-term company performance.

Next Steps

• Vesting of the 14,965 deferred stock units on June 10, 2027.

Key Dates

Keywords

Orthofix Medical, OFIX, Form 4, Insider Trading, Director Compensation, Equity Grant